Legislation pharmaceutical industry

Sanders N. 1993. Food legislation and the scope for increased use of near-critical fluid extraction operations in food, flavoring and pharmaceutical industries. In King MB and Bott TR, editors. Extraction of Natural Products Using Near-Critical Solvents. Glasgow Blackie Academic, pp. 34 19. 

Following extensive discussions among aU interested parties, such as the national authorities, the EC and the European Federation of Pharmaceutical Industries and Associations (EFPIA), the EC proposed comprehensive reform of the EU pharmaceutical legislation. The amending legislations are ... 

Legislation introduced in 2008 proposes to use this new standard. The Comparative Effectiveness Research Act of 2008 would create an institute to review and publicize evidence on how to best treat diseases, disorders, and other health conditions. In evaluating the effectiveness of drugs and medical procedures, the institute would provide unbiased information to health care practitioners. Information on the most effective treatment rather than the most heavily advertised and expensive treatment would ideally reduce costs. The pharmaceutical industry also favors the legislation. A version of this legislation passed as part of the American Recovery and Reinvestment Act of 2009. The act provided funds to several agencies and created a Federal Coordinating Council for Comparative Effectiveness Research to advance comparative effectiveness research. 

Richmond, Lesley, Julie Stevenson and Alison Turton, eds. The Pharmaceutical Industry A Guide to Historical Records. Aldershot, Hampshire, England Ashgate, 2003. This guide facilitates the study of the pharmaceutical industry in Britain by providing information on the location of archives and company records. Few will want to examine the archives, but the book also includes brief histories of some companies, a chronology of pharmaceutical legislation, and essays by experts on the history of the industry. The material on Britain shows both similarities and differences to the history of the pharmaceutical industry in the United States. 

Rifino, C. B. A philosophical view of certain personnel considerations in validation. Purdue University Management Conference for the Pharmaceutical Industry Regulation, Legislation, Economics and the Drug Industry, part II, 1979. 

There have been four pivotal legislative developments between 1995 and 2000 impacting the pharmaceutical industry ... 

---